✦ LIBER ✦

1–4 Effect of Factor V Leiden and Prothrombin G20210 → A Mutations on Thromboembolic Risk in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial

✍ Scribed by Cook, E.D.

Book ID: 122430306
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 120 KB
Volume: 18
Category: Article
ISSN: 1043-321X
DOI: 10.1016/S1043-321X(07)80009-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Factor V Leiden, prothrombin G20210A and

Factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms and the risk of tamoxifen-associated thromboembolism in breast cancer patients

✍ Aydan Eroğlu; Nejat Akar 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Tamoxifen for Prevention of Breast Cance

Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

✍ Fisher, B.; Costantino, J. P.; Wickerham, D. L.; Redmond, C. K.; Kavanah, M.; Cr 📂 Article 📅 1998 🏛 Oxford University Press 🌐 English ⚖ 322 KB

Compliance with quality of life data col

Compliance with quality of life data collection in the National Surgical Adjuvant Breast and Bowel Project (NSABP) Breast Cancer Prevention Trial

✍ Patricia A. Ganz; Richard Day; Joseph Costantino 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 2 views

This paper describes compliance with the completion of a quality of life questionnaire in the Breast Cancer Prevention Trial, a large multi-centre randomized trial that is studying the efficacy of Tamoxifen in preventing breast cancer. In the first 4875 women enrolled in the control arm of the study